Herrera, F. 2024. LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT. Mediterranean Journal of Hematology and Infectious Diseases. 16, 1 (Apr. 2024), e2024039. DOI:https://doi.org/10.4084/MJHID.2024.039.